Table 1.
Patient demographic data and pathology. W.H.O.: World Health Organization.
| Patient information |
|||
|---|---|---|---|
| Patient | Age | Gender | Tumor type |
| P1 | 28 | F | Oligodendrioma, W.H.O. grade II |
| P2 | 34 | F | Recurrent metastatic carcinoma, lung primary |
| P3 | 57 | M | Glioblastoma (GBM), W.H.O. Grade IV |
| P4 | 66 | F | Glioblastoma (GBM), W.H.O. Grade IV |
| P5 | 63 | M | Metastatic melanoma |
| P6 | 52 | F | Metastatic carcinoma, breast primary |
| P7 | 70 | M | Anaplastic astrocytoma, W.H.O. Grade III |
| P8 | 26 | F | Anaplastic astrocytoma, W.H.O. Grade III |
| P9 | 57 | F | Diffuse astrocytoma W.H.O. grade II |
| P10 | 59 | F | Low grade glial/glioneuronal tumor |
| P11 | 57 | M | Glioblastoma (GBM), W.H.O. Grade IV |
| P12 | 52 | M | Malignant spindle cell neoplasm |
| P13 | 51 | F | Glioblastoma (GBM), W.H.O. Grade IV |
| P14 | 51 | M | Glioblastoma (GBM), W.H.O. Grade IV |
| P15 | 38 | M | Anaplastic astrocytoma, W.H.O. Grade III |
| P16 | 70 | F | Glioblastoma (GBM), W.H.O. Grade IV |
| P17 | 23 | M | Anaplastic astrocytoma, W.H.O. Grade III |
| P18 | 34 | F | Diffuse astrocytoma, W.H.O. Grade II |